STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLDI
  4. [EFFECT] Calidi Biotherapeutics, Inc. SEC Filing

[EFFECT] Calidi Biotherapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:30 P.M.
Form: S-1
CIK: 0001855485
Company Name: Calidi Biotherapeutics, Inc.
File Number: 333-288529

Source: View Original Filing on SEC EDGAR

Calidi Biotherapeutics Inc

NYSE:CLDI

View CLDI Stock Overview →

CLDI Rankings

#6885 Ranked by Market Cap
N/A Ranked by Dividends

CLDI Latest News

Mar 12, 2026
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company’s Approach to Manufacturing
Mar 9, 2026
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option
Mar 6, 2026
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
Mar 5, 2026
Calidi Biotherapeutics Announces Proposed Public Offering
Feb 20, 2026
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

CLDI Latest SEC Filings

Mar 11, 2026
[8-K] Calidi Biotherapeutics, Inc. Reports Material Event
Mar 9, 2026
[SCHEDULE 13D] Calidi Biotherapeutics, Inc. Major Shareholder Acquisition (>5%)
Mar 6, 2026
[424B5] Calidi Biotherapeutics, Inc. Prospectus Supplement (Debt Securities)
Mar 5, 2026
[424B5] Calidi Biotherapeutics, Inc. Prospectus Supplement (Debt Securities)
Feb 10, 2026
[SCHEDULE 13G/A] Calidi Biotherapeutics, Inc. Amended Passive Investment Disclosure

CLDI Stock Data

2.85M
6.31M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SAN DIEGO